Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 7:55 PM View:  | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 01-Oct-24 | Planned Option Sale | 11,000 | $46.28 | $509,080.00 | (25%) 43.44K to 32.44K | |
| 01-Oct-24 7:55 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 01-Oct-24 | Option Exercise | 11,000 | $3.29 | $36,190.00 | 34% 32.44K to 43.44K | |
| 01-Oct-24 7:55 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 27-Sep-24 | Gift | 830 | -- | -- | 3% 31.61K to 32.44K | |
| 19-Sep-24 6:34 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 18-Sep-24 | Disposition (other) | 7,250 | -- | -- | (18%) 39.27K to 32.02K | |
| 19-Sep-24 6:34 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 18-Sep-24 | Gift | 870 | -- | -- | (2%) 40.14K to 39.27K | |
| 19-Sep-24 6:34 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 17-Sep-24 | Gift | 300 | -- | -- | (< 1%) 40.44K to 40.14K | |
| 05-Sep-24 7:57 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Payment of Exercise | 254 | $35.30 | $8,966.20 | (< 1%) 33.45K to 33.19K | |
| 05-Sep-24 8:27 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Grant | 744 | $17.13 | $12,744.70 | 8% 9.29K to 10.03K | |
| 05-Sep-24 8:08 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Grant | 916 | $17.13 | $15,691.10 | < 1% 104.4K to 105.31K | |
| 05-Sep-24 8:04 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Option Exercise | 10,000 | $21.65 | $216,500.00 | 166% 6.04K to 16.04K | |
| 05-Sep-24 8:27 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Payment of Exercise | 129 | $35.30 | $4,553.70 | (1%) 10.03K to 9.9K | |
| 05-Sep-24 8:08 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Payment of Exercise | 232 | $35.30 | $8,189.60 | (< 1%) 105.31K to 105.08K | |
| 05-Sep-24 8:24 PM View: | Mokari Atabak Chief Financial Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Grant | 800 | $17.13 | $13,704.00 | 7% 11.86K to 12.66K | |
| 05-Sep-24 8:04 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Planned Option Sale | 10,000 | $35.30 | $353,000.00 | (63%) 15.8K to 5.8K | |
| 05-Sep-24 7:57 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Grant | 1,006 | $17.13 | $17,232.80 | 3% 32.44K to 33.45K | |
| 05-Sep-24 8:24 PM View: | Mokari Atabak Chief Financial Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Payment of Exercise | 143 | $35.30 | $5,047.90 | (1%) 12.66K to 12.52K | |
| 05-Sep-24 8:04 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 03-Sep-24 | Payment of Exercise | 243 | $35.30 | $8,577.90 | (2%) 16.04K to 15.8K | |
| 28-Aug-24 5:59 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 26-Aug-24 | Private Sale | 3,101 | $35.71 | $110,737.00 | (9%) 35.54K to 32.44K | |
| 05-Aug-24 6:31 PM View: | Hunt Hazel Chief Scientific Officer | Corcept Therapeutics Inc. (CORT) | 01-Aug-24 | Option Exercise | 60,000 | $2.81 | $168,600.00 | 64% 93.35K to 153.35K | |
| 05-Aug-24 7:10 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Aug-24 | Option Exercise | 150 | $5.86 | $879.00 | 100% 0 to 0.15K | |
| 05-Aug-24 6:56 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 01-Aug-24 | Option Exercise | 10,000 | $21.65 | $216,500.00 | 166% 6.04K to 16.04K | |
| 05-Aug-24 6:56 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 01-Aug-24 | Planned Option Sale | 10,000 | $38.67 | $386,700.00 | (62%) 16.04K to 6.04K | |
| 05-Aug-24 6:31 PM View: | Hunt Hazel Chief Scientific Officer | Corcept Therapeutics Inc. (CORT) | 01-Aug-24 | Payment of Exercise | 34,773 | $37.94 | $1,319,290.00 | (23%) 153.35K to 118.58K | |
| 05-Aug-24 7:10 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 01-Aug-24 | Planned Option Sale | 150 | $38.50 | $5,775.00 | (100%) 0.15K to 0 | |
| 02-Aug-24 4:42 PM View: | Belanoff Joseph K Chief Executive Officer Director | Corcept Therapeutics Inc. (CORT) | 31-Jul-24 | Payment of Exercise | 259,583 | $38.67 | $10,038,100.00 | (8%) 3.28M to 3.02M | |
| 02-Aug-24 4:42 PM View: | Belanoff Joseph K Chief Executive Officer Director | Corcept Therapeutics Inc. (CORT) | 31-Jul-24 | Option Exercise | 450,000 | $3.29 | $1,480,500.00 | 16% 2.83M to 3.28M | |
| 03-Jul-24 5:13 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 01-Jul-24 | Planned Option Sale | 10,000 | $32.49 | $324,900.00 | (62%) 16.04K to 6.04K | |
| 03-Jul-24 5:16 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Jul-24 | Planned Option Sale | 5,000 | $32.49 | $162,452.00 | (35%) 14.29K to 9.29K | |
| 03-Jul-24 5:13 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 01-Jul-24 | Option Exercise | 10,000 | $21.65 | $216,500.00 | 166% 6.04K to 16.04K | |
| 03-Jul-24 5:16 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 01-Jul-24 | Option Exercise | 5,000 | $11.35 | $56,750.00 | 54% 9.29K to 14.29K | |
| 24-Jun-24 6:47 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 24-Jun-24 | Disposition (other) | 1,000 | -- | -- | (3%) 36.54K to 35.54K | |
| 24-Jun-24 6:47 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 24-Jun-24 | Gift | 1,650 | -- | -- | 4% 37.54K to 39.19K | |
| 24-Jun-24 6:47 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 24-Jun-24 | Gift | 2,650 | -- | -- | (7%) 39.19K to 36.54K | |
| 06-Jun-24 6:21 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 04-Jun-24 | Payment of Exercise | 8,174 | $32.87 | $268,679.00 | (18%) 45.81K to 37.64K | |
| 06-Jun-24 6:21 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 04-Jun-24 | Option Exercise | 14,000 | $3.29 | $46,060.00 | 44% 31.82K to 45.81K | |
| 05-Jun-24 9:10 PM View: | Mokari Atabak Chief Financial Officer | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Payment of Exercise | 571 | $30.17 | $17,227.10 | (5%) 12.43K to 11.86K | |
| 05-Jun-24 9:15 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Payment of Exercise | 488 | $30.17 | $14,723.00 | (3%) 14.78K to 14.29K | |
| 05-Jun-24 9:15 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Planned Option Sale | 5,000 | $30.18 | $150,916.00 | (35%) 14.29K to 9.29K | |
| 05-Jun-24 9:11 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Option Exercise | 10,000 | $19.26 | $192,600.00 | 166% 6.04K to 16.04K | (< 1%) |
| 05-Jun-24 9:15 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Planned Option Sale | 2,200 | $30.21 | $66,462.00 | (100%) 2.2K to 0 | |
| 05-Jun-24 9:19 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Grant | 3,636 | $15.65 | $56,903.40 | 13% 28.9K to 32.54K | |
| 05-Jun-24 9:15 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Option Exercise | 5,000 | $11.35 | $56,750.00 | 51% 9.78K to 14.78K | |
| 05-Jun-24 9:13 PM View: | Maduck Sean See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Payment of Exercise | 823 | $30.17 | $24,829.90 | (< 1%) 105.22K to 104.4K | |
| 05-Jun-24 9:15 PM View: | Swisher Daniel N Jr Director | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Option Exercise | 2,200 | $5.86 | $12,892.00 | 100% 0 to 2.2K | |
| 05-Jun-24 9:10 PM View: | Mokari Atabak Chief Financial Officer | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Grant | 2,896 | $15.65 | $45,322.40 | 30% 9.54K to 12.43K | |
| 05-Jun-24 9:11 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Planned Private Option Sale | 10,000 | $32.00 | $320,000.00 | (62%) 16.04K to 6.04K | |
| 05-Jun-24 9:19 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Payment of Exercise | 724 | $30.17 | $21,843.10 | (2%) 32.54K to 31.82K | |
| 05-Jun-24 9:15 PM View: | Lyon Joseph Douglas See Remarks | Corcept Therapeutics Inc. (CORT) | 03-Jun-24 | Grant | 2,464 | $15.65 | $38,561.60 | 34% 7.31K to 9.78K | |
| 30-May-24 8:03 PM View: | Guyer William Chief Development Officer | Corcept Therapeutics Inc. (CORT) | 28-May-24 | Option Exercise | 30,000 | $19.26 | $577,800.00 | 497% 6.04K to 36.04K | (< 1%) |
| 30-May-24 9:00 PM View: | Robb Gary Charles Chief Business Officer | Corcept Therapeutics Inc. (CORT) | 28-May-24 | Planned Option Sale | 11,000 | $30.39 | $334,294.00 | (28%) 39.9K to 28.9K |
